CN104188979B - 闭花木酮Cleistanone的O-(吗啉基)乙基衍生物在制备治疗缺血性脑损伤药物中的应用 - Google Patents
闭花木酮Cleistanone的O-(吗啉基)乙基衍生物在制备治疗缺血性脑损伤药物中的应用 Download PDFInfo
- Publication number
- CN104188979B CN104188979B CN201410392605.XA CN201410392605A CN104188979B CN 104188979 B CN104188979 B CN 104188979B CN 201410392605 A CN201410392605 A CN 201410392605A CN 104188979 B CN104188979 B CN 104188979B
- Authority
- CN
- China
- Prior art keywords
- cleistanone
- morpholinyl
- ethyl derivative
- brain injury
- ischemic brain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 CCCOCC*CCOC(CC(C)(C(C)(CC1)C(*)(CC2)CC1(C(C)(C)CC1)C1=C)C2(*)C1(C)CCC(*2(C)C)=O)C12[I+] Chemical compound CCCOCC*CCOC(CC(C)(C(C)(CC1)C(*)(CC2)CC1(C(C)(C)CC1)C1=C)C2(*)C1(C)CCC(*2(C)C)=O)C12[I+] 0.000 description 2
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410392605.XA CN104188979B (zh) | 2014-08-11 | 2014-08-11 | 闭花木酮Cleistanone的O-(吗啉基)乙基衍生物在制备治疗缺血性脑损伤药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410392605.XA CN104188979B (zh) | 2014-08-11 | 2014-08-11 | 闭花木酮Cleistanone的O-(吗啉基)乙基衍生物在制备治疗缺血性脑损伤药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104188979A CN104188979A (zh) | 2014-12-10 |
CN104188979B true CN104188979B (zh) | 2017-01-11 |
Family
ID=52074456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410392605.XA Active CN104188979B (zh) | 2014-08-11 | 2014-08-11 | 闭花木酮Cleistanone的O-(吗啉基)乙基衍生物在制备治疗缺血性脑损伤药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104188979B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107793404A (zh) * | 2017-11-07 | 2018-03-13 | 全椒先奇医药科技有限公司 | 一种治疗缺血性脑损伤药物组合物及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI454269B (zh) * | 2003-12-23 | 2014-10-01 | Pacific Arrow Ltd | 由文冠果(xanthoceras sorbifolia)單離之化合物、其製備方法以及其用途 |
NZ580702A (en) * | 2007-04-30 | 2012-03-30 | Leo Lab Ltd | Treatment of virally induced lesions |
CN103342729B (zh) * | 2013-03-26 | 2016-09-14 | 中国科学院上海药物研究所 | 咖啡酰基取代的五环三萜类衍生物及其用途 |
CN103450297A (zh) * | 2013-08-05 | 2013-12-18 | 南京标科生物科技有限公司 | 一种闭花木苷的制备方法 |
-
2014
- 2014-08-11 CN CN201410392605.XA patent/CN104188979B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN104188979A (zh) | 2014-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104188979B (zh) | 闭花木酮Cleistanone的O-(吗啉基)乙基衍生物在制备治疗缺血性脑损伤药物中的应用 | |
CN101289438A (zh) | 3-(3′-羟基)-丁基苯酞酯及其制法和用途 | |
CN102872048B (zh) | Gypensapogenin B在制备治疗缺血性脑损伤药物中的应用 | |
CN104490897B (zh) | 闭花木酮的o-(咪唑基)乙基衍生物在制备治疗缺血性脑损伤药物中的应用 | |
CN103705504B (zh) | Myrtucommuacetalone在治疗缺血性脑损伤药物中的应用 | |
CN109248165A (zh) | 一种具有提高免疫力作用的化合物及其在制备提高免疫力药物中的应用 | |
CN100441589C (zh) | 含水溶性基团的葛根素化合物及其制法和用途 | |
CN106309454A (zh) | Friedolanostanes在制备治疗缺血性脑损伤药物中的应用 | |
CN103751181B (zh) | 一种化合物在治疗缺血性脑损伤药物中的应用 | |
CN112469708B (zh) | 一类具有神经保护作用的化合物及其制备方法和用途 | |
CN103381174B (zh) | Houttuynoid E在制备治疗缺血性脑损伤药物中的应用 | |
CN103356644B (zh) | Chukrasone A在制备治疗缺血性脑损伤药物中的应用 | |
CN103381154B (zh) | Chukrasone B在制备治疗缺血性脑损伤药物中的应用 | |
CN103622963B (zh) | Trigolutesins A在治疗缺血性脑损伤药物中的应用 | |
CN103381179B (zh) | Houttuynoid D在制备治疗缺血性脑损伤药物中的应用 | |
CN103356666B (zh) | Houttuynoid A在制备治疗缺血性脑损伤药物中的应用 | |
CN103385887B (zh) | Houttuynoid C在制备治疗缺血性脑损伤药物中的应用 | |
CN105055409A (zh) | 一种治疗缺血性脑损伤药物及其应用 | |
CN102885824B (zh) | Gypensapogenin A在治疗缺血性脑损伤药物中的应用 | |
CN103127088A (zh) | Eryngiolide A在治疗缺血性脑损伤药物中的应用 | |
CN106580952A (zh) | 一种治疗缺血性脑损伤药物及其应用 | |
CN103463003B (zh) | Racemosins A在制备治疗缺血性脑损伤药物中的应用 | |
CN106265677B (zh) | 一种防治溃疡性结肠炎的药物组合物及其应用 | |
CN104922127B (zh) | 式2化合物在制备治疗和/或预防偏头痛及其并发症的药物中的用途 | |
CN105412085A (zh) | Cathepsin L在制备治疗缺血性脑损伤药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Pingchang Inventor after: Shen Cuan Inventor after: Lin Huatu Inventor after: Shuai Jishan Inventor before: Wu Junyi Inventor before: Huang Rong Inventor before: Wu Junhua |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160929 Address after: 225300, Jiangsu, Taizhou Economic Development Zone, No. drug City Avenue (eastern side of the road on the north side of the Park Road) new drug creation base, phase two, D building, room 1612 Applicant after: Taizhou Xiangtai Hong Wah Medical Technology Co Ltd Address before: Metro Technology Building No. 69 Olympic Avenue in Jianye District of Nanjing city in Jiangsu province 210019 01 5 storey buildings Applicant before: Nanjing Guangkangxie Biomedical Technology Co., Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant |